Field of the Invention
This invention is generally in the field of catheters to accomplish arterial, transluminal atherectomy and more specifically, is a guide wire following system for tunneling a lumen through an arterial stenosis so as to directly increase blood flow or as a precursor to balloon angioplasty or some other means for increasing arterial blood flow.
Background of the Invention
Atherosclerotic arterial disease is the leading cause of morbidity and mortality in the United States and most other developed countries. Atherosclerosis is a chronic disease process characterized by lipid deposits and fibrosis of the intima, irregularly distributed in large and medium sized arteries. The disease is progressive and most often becomes clinically manifest in the middle-aged and elderly. When severe, the atherosclerotic plaque causes a reduction of the cross-sectional area of the arterial lumen, with and without thrombosis. Resultant ischemic manifestations include: angina pectoris, myocardial infarction, stroke, intermittent claudication, gangrene of the lower extremities and renovascular hypertension.
The current management of atherosclerotic disease includes preventative therapy aimed at minimizing known major risk factors such as hypertension, smoking, hypercholesterolemia and diabetes mellitus.
Coronary artery bypass grafting (CABG), carotid endarterectomy and bypass grafting (autogenous vein or synthetic graft) of the iliac, femoral and renal arteries are all well established surgical methods of palliative therapy. Although these procedures are often effective in relieving ischemia, each of these represents a major surgical operation with significant associated morbidity, mortality and expense. CABG, for example, requires the opening of the chest cavity (thoracotomy) and use of cardiopulmonary bypass, with not uncommon postoperative complications including postperiocardotomy syndrome, Non-A Non-B hepatitus, stroke and a mortality of approximately one percent (1%) at most medical centers.
Percutaneous transluminal angioplasty (PTA) by means of a balloon catheter is a relatively new ("non-surgical") procedure with proven efficacy in relief of atherosclerotic obstruction of the coronary, renal and peripheral circulations. The technique involves the percutaneous passage (under local anesthesia) of a specialized balloon-tipped catheter through the site of arterial narrowing, and inflation of the balloon to reduce obstruction. This is always done in conjunction with angiographic visualization of the vessel being treated. When successful, this procedure results in a reduction of the arterial stenosis and a decrease in the transstenotic pressure gradient. The mechanism of action is felt to consist of some combination of plaque compression, intimal splitting and medial/adventitial stretching. Healing of the balloon-damaged plaque may involve fibrosis and retraction of the split intimal elements, with further luminal enlargement in the weeks to months following the procedure.
The safety and efficacy of PTA is a function of the vessel being treated, patient selection, and the expertise of the physician performing the procedure. Primary angiographic success, defined as a 20% or greater reduction of stenosis, is now achieved in approximately 80-90% of attempts in carefully selected patients at experienced centers. The obvious advantage of PTA, compared to surgical palliative therapy, is that it does not require major surgery or general anesthesia with the associated sequelae.
Despite its proven efficacy in the palliation of obstructive atherosclerotic disease, PTA, as it is currently performed, has several important technical limitations. These limitations are particularly true in the application of PTA to the coronary circulation.
Even in the most skilled hands, dilation of an arterial obstruction is currently not achievable in approximately 20% of attempts. The most common cause of failed PTA is the inability to pass either the guide wire or dilating catheter through the site of a tight or eccentric stenosis. This problem is even more common in attempts to dilate the difficult to access right and circumflex coronary arteries. Although technical advances, such as steerable catheters, have reduced the frequency of unsuccessful attempts, inability to cross a tight, eccentric or fully closed stenosis remains a major limitation of PTA.
Attempts at balloon or guide wire passage in vessels which are tightly stenotic may lead to arterial dissection and/or acute occlusion necessitating emergency vascular surgery. This major complication occurs in 6-8% of attempts at coronary angioplasty.
Inability to dilate an obstruction, even after proper balloon positioning and inflation is a second common mode of PTA failure. This problem is most frequently encountered in older plaques which are densely fibrotic and/or calcified.
Restenosis of the obstructed arterial segment following successful PTA is a major problem with the current technique. This problem is more common following PTA of a coronary obstruction (30-35% at one year) than in the peripheral circulation (10-15% at two years). Pharmacologic attempts to reduce the incidence of restenosis have been largely unsuccessful.
Distal embolization of atherosclerotic plaque following balloon PTA occurs in approximately 5% of patients undergoing PTA of lower extremity or renal arteries. Although these emboli are usually clinically insignificant in these vascular territories, such embolization could be catastrophic in the cerebral circulation. For this reason, balloon PTA is considered to be constraindicated for the treatment of obstructive lesions in the arteries of the aortic arch, such as the carotid artery.
In U.S. Pat. No. 4,207,874 (dated June 17, 1980) D. S. J. Choy describes a means for using a laser beam to tunnel though an arterial occlusion by vaporization of the obstruction. The difficulty with Choy's invention is that that there is insufficient means to prevent simultaneous destruction of the arterial wall. For example, the Choy invention shows an intense laser beam directed in the forward direction without significant beam attenuation in that direction. If the artery were to curve and the arterial wall was exposed to the laser beam, the wall could also be vaporized which could be catastrophic for the patient. Although the Choy invention describes a means for direct visualization of the obstructed region, it does not describe a centering means or a guide wire following means in order to guarantee that the laser beam does not illuminate part of the arterial wall. Furthermore, the Choy invention may completely obstruct a partially obstructed artery thereby cutting off blood flow to distal tissues for a significant time period. The result is ischemia which could cause irreparable damage to heart or brain tissue.
In U.S. Pat. No. 4,273,128 (date June 16, 1981) B. G. Larry describes a "Coronary Cutting and Dilating Instrument" used for operating a coronary stenosis that is restricting blood flow. The device described by Lary could not be used in a completely or nearly completely occluded artery because its "blunt ovoid tip" could not pass through a completely occluded vessel. Furthermore, the Lary invention does not have any means to prevent its cutting blade from cutting through the arterial wall as well as occluding the stenotic material. Furthermore, there is no means taught in the Lary patent for centering the cutting blade within the arterial walls. Thus, if the probe wire 13 (of FIG. 10) of the Lary invention guides the knife through a highly eccentric lumen within the stenotic plaque its knife blade would surely cut through the arterial wall which would have serious adverse effects for the patient.
In the Research Resources Reporter, September 1984, Vol. VIII, No. 9 published by the U.S. Department of Health and Human Services, National Institutes of Health, Margaret Patlak published an article entitled, "Balloon Catherization Opens Totally Blocked Coronary Arteries." This article describes how it is possible to push guide wires through the comparatively soft, center section of an essentially fully occluded artery. Once the guide wire can be pushed through, it was reported that 31 or 45 patients were then able to have a balloon catheter pushed through. Subsequent balloon dilation increased blood flow in each of the 31 patients. However, it would be of considerable value if the 14 patients (27% of the cases) whose stenoses were too tight to allow the passage of the balloon catheter were able to be treated by some means other than surgery. The present invention is related to but different from a prior invention described in a previous patent application, Ser. No. 694,746, now abandoned, filed on Jan. 25, 1985 by Robert E. and Tim A. Fischell which is entitled " A Tunneling Catheter System for Transluminal Arterial Angioplasty." The prior application envisions a tunneling catheter that references the interior surface of the arterial wall before tunneling a hole in the stenotic plaque. The present invention is considerably simpler in concept in that the cutting edge of the tunneling catheter merely follows a guide wire that has already penetrated the narrowed opening in the stenotic plaque.
Thus, it is the goal of the present invention to eliminate the numerous shortcomings of the prior art in order to provide a device which can safely tunnel a clean hole through a narrow partially occluded or fully occluded arterial stenosis.
Summary of the Invention
The guide wire tunneling atherectomy catheter system described herein is capable of being advanced within a guiding catheter and over a guide wire until it is in contact with an occlusion that is penetrated by the guide wire. During visualization via biplane fluoroscopy, the tunneling catheter is then advanced into plaque which forms the arterial occlusion. The tunneling catheter is generally in the shape of a hollow cylinder with a sharp cutting edge. A bore cylinder of the plaque is caused to enter an interior volume of the advancing tunneling catheter. The bore cylinder is held in place in that volume by means of a suction applied at the proximal end of the tunneling catheter whose hollow lumen is in fluid communication with the distal end of the catheter. When the tunneling catheter is removed from the body (typically along with the guide wire) the bore cylinder of plaque is also removed, thus opening the arterial lumen.
Several methods are possible to promote cutting by the sharpened distal end which is the cutting edge of the cylindrical tunneling catheter. One method is merely to advance the extremely sharp distal cutting edge; another method is to rotate the tunneling catheter's cutting edge as it is advanced. Another method is to apply a high energy ultrasonic vibration into the tunneling catheter from its proximal end causing the sound energy to be readily transmitted by conduction to the catheter's cutting edge. Another method for deftly cutting through the plaque is by applying an electrocautery alternating current to the cutting edge.
Once a tunnel has been made in the plaque, a balloon angioplasty catheter could be advanced into the partially opened occlusion. The balloon can then be expanded to further dilate the opening as is well known in the art of percutaneous transluminal balloon angioplasty. Another method for enlarging the opening may be by utilizing a second tunneling catheter that has a larger outer diameter than the first used and is specifically designed to center itself in the opening made by the first guide wire following, tunneling catheter. The first tunnel that is bored in the plaque may of itself be of sufficient diameter to allow adequate blood flow without the subsequent use of an angioplasty balloon catheter or an enlarging tunneling catheter.
Thus an object of this invention is to tunnel a hole through an arterial occlusion, particularly an occlusion that is nearly fully or totally occluded or which has a narrowed passageway that is centrally or eccentrically located relative to the center of the arterial lumen.
Another object of the present invention is to employ a sharpened, cylindrical edge of a tunneling catheter to cut through the plaque either by directly pushing on it or by rotating it while advancing its sharpened distal edge through the plaque.
Still another object of the present invention is to utilize ultrasonic vibration of the cylindrical cutting edge to facilitate its ability to cut through the plaque.
Still another object of the present invention is to utilize an electrocautery to apply an electric current to the cutting edge of the tunneling catheter to enhance its ability to cut through the occlusion.
Still another object of this invention is to first use a guide wire following tunneling catheter system to bore a tunnel into the plaque and then use balloon angioplasty to further enlarge the lumen of the stenotic plaque.
Still another object of this invention is to first use a guide wire following tunneling catheter system to bore a tunnel into the plaque and then use a tunneling type of enlarging tool at the catheter's distal end to further enlarge the lumen of the stenotic plaque.
Still another object of the present invention is to apply this technique to any occluded artery including the coronary arteries, the carotoid artery, the renal artery and the arteries of the legs and arms.
Detailed Description of the Invention
FIG. 1 shows the configuration of the guide wire tunneling catheter 20 at its distal end 22 with the guide wire 10 being shown at it penetrates a narrow stenosis consisting of plaque P within an arterial wall AW. To achieve this condition a guiding catheter 50 would first be placed through the femoral artery in a conventional manner and then advanced in a conventional manner until its distal end lies just proximal to the plaque P. At this point the procedure, the artery would be visualized with image intensified fluoroscopy which should show that the sharpened edge 22a of the distal end 22 of the tunneling catheter 20 is just proximal to the plaque P.
FIG. 2 shows the configuration of the proximal end of the guide wire tunneling catheter 20 as it lies just outside the patient's body. The catheter cylinder's proximal end 23 is joined by a press fit or adhesive into the handle 26. The guide wire 10 is shown penetrating a felt or foam rubber seal 28 that is set into the handle 26. The interior region 24 (of FIGS. 1 and 2) lying between the outer surface of the guide wire 10 and the interior cylindrical surface of the tunneling catheter 20 allows fluid communication between the port 26a and the interior of the catheter's distal end 22. For example, a suction can be applied at the port 26a which suction is communicated to the interior region 24 and then to the catheter's sharpened edge 22a as it is advanced through the plaque P. The port 26a can also be used for injection of a radio-opaque dye to better visualize the stenotic artery.
When fluoroscopy indicates that the sharpened edge 22a is just in contact with the plaque P, then suction is applied simultaneously with advancing the catheter cylinder 22 into the plaque P. Rotating the handle while advancing the tip 22a through the plaque will enhance the cutting action. The rotational motion may optimally be oscillatory. By applying an ultrasonic vibrational input U (as shown in FIG. 2) on the handle 26, the cutting action of the tip 22a will also be enhanced. Also, an electrocautery current applied to the tip 22a (as described in the referenced patent application Ser. No. 694,746) could also be used for enhancing the cutting action of the tip 22a. Then either the entire catheter 20 is removed from the body by itself or preferably it is removed simultaneously with the guide wire 10. The suction is maintained until the entire catheter 20 and guide wire 10 are completely removed from the body. When this is done a small but finite portion of the plaque P is removed thus enlarging the narrow opening of the stenotic plaque P.
After an initial enlargement has been made by the tunneling catheter 20, a conventional angioplasty balloon catheter (not shown) could have its balloon tip advanced into the enlarged opening and dilated in a conventional manner to further open the stenotic lumen in order to further increase blood flow. However an alternative procedure using an enlarging tunneling catheter as shown in FIG. 3 could be used. FIG. 3 shows just the distal end 36 of such an enlarging catheter 30. FIG. 3 also shows the plaque P after it has had a cylinder bore volume removed by the guide wire following tunneling catheter 20. The interior lumen of the cut plaque P would then be large enough for either conventional balloon dilation or the application of a larger diameter tunneling catheter such as that shown in FIG. 3.
The distal end 36 of the enlarging tunneling catheter 30 would have a sharpened edge 36a and a small diameter central cylinder 32 having an interior lumen 31 which typically surrounds a guide wire (not shown) that is first advanced through a guiding catheter (also not shown) and then advanced into the enlarged interior lumen of the plaque P. Thus the enlarging tunneling catheter 30 is typically advanced along a guide wire (like guide wire 10 of FIG. 1) and within a guiding catheter such as that shown as catheter 50 in FIG. 1. The central cylinder 32 is held along the longitudinal axis of the distal end 36 of the enlarging tunneling catheter 30 by means of a separator 34 that is also shown in cross section in FIG. 4.
Between the interior surface of the distal end 36 and the exterior surface of the central cylinder 32 is an annular chamber 40 that is in fluid communication through holes 35 (see FIG. 4) of the separator 34 with the interior chamber 42 of the enlarging catheter 30 that lies on the proximal side of the separator 34 and within a plastic cylinder 38 that joins outside the body to a handle similar to the handle 26 shown in FIG. 2. Thus a suction applied at the proximal end of the plastic cylinder 38 of the enlarging catheter 30 can be used during the cutting process to hold that portion of the plaque P that can be removed when the sharpened edge 36a is advanced through the plaque P. After that is accomplished, the entire enlarging tunneling catheter 30 can be removed (while still applying suction at its proximal end) without removing the guide wire (not shown) and without removing the guiding catheter (also not shown).
As is the case with the guide wire following tunneling catheter 20 of FIGS. 1 and 2, the cutting action of the enlarging catheter 30 can be accomplished by simply pushing it forward, or manually rotating it while advancing it or by the application of ultrasonic vibration from the proximal end handle as has already been described herein, or by application of an electrocautery current as described in U.S. patent application Ser. No. 694,746.
As far as materials are concerned, the tunneling catheter 20 would typically have a Type 316 stainless steel cylinder 22 and a plastic handle typically made from PVC or acetal. The outer diameter of the cylinder portion of the catheter 20 would typically be 1.0 to 1.5 mm with a wall thickness of approximately 0.1 mm. The guide wire 10 would typically be Teflon coated steel wire with 0.5 mm outside diameter. The guiding catheter 50 would be typically 6 to 12 French depending on the artery into which its distal end would be placed. The entire distal end of the enlarging tunneling catheter 30 would typically be made from Type 316 stainless steel. The outer diameter of the central cylinder 32 (of FIG. 3) would typically be 1.0 to 1.2 mm with 0.15 mm wall thickness. The length of the annular chamber 40 would typically be 1 to 3 cm depending on the length of plaque P that is to be cut. The plastic cylinder 38 would typically be made from PVC. The outer diameter of the enlarging tunneling catheter 30 would be selectable between 2 and 10 mm depending on the particular artery into which it would be advanced. The distal coronary arteries might require a 2 mm diameter. The carotid artery might use a 10 mm diameter enlarging tunneling catheter.
Various other modifications, adaptations and alternative designs are of course possible in light of the above teachings. Therefore, it should be understood at this time that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described therein.